Hennion & Walsh Asset Management, Inc. Ironwood Pharmaceuticals Inc Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.06 Billion
- Q3 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 170,811 shares of IRWD stock, worth $602,962. This represents 0.03% of its overall portfolio holdings.
Number of Shares
170,811
Previous 129,649
31.75%
Holding current value
$602,962
Previous $845,000
16.92%
% of portfolio
0.03%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding IRWD
# of Institutions
238Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$80.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$77.8 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$57.9 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$39.8 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$35 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $541M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...